Phocas Financial Corp. Acadia Pharmaceuticals Inc Transaction History
Phocas Financial Corp.
- $695 Billion
- Q2 2025
A detailed history of Phocas Financial Corp. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Phocas Financial Corp. holds 102,176 shares of ACAD stock, worth $2.2 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
102,176
Previous 102,161
0.01%
Holding current value
$2.2 Million
Previous $1.7 Billion
29.88%
% of portfolio
0.32%
Previous 0.26%
Shares
9 transactions
Others Institutions Holding ACAD
# of Institutions
345Shares Held
163MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$924 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$329 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$260 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$194 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$133 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.49B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...